All Title Author
Keywords Abstract


Comparison between Preoperative and Postoperative Sublingual Misoprostol for Prevention of Postpartum Hemorrhage during Cesarean Section: A Randomized Clinical Trial

DOI: 10.4236/ojog.2019.94052, PP. 529-538

Keywords: Blood Loss, Cesarean Section, Misoprostol, Postpartum Hemorrhage

Full-Text   Cite this paper   Add to My Lib

Abstract:

Background: Blood loss is one of the important complications during cesarean section (CS). Previous reports have shown that misoprostol is effective in reducing blood loss during and after CS. However, the optimum time for its administration to decrease the amount of PPH is still under discussion. Objective: To compare the effect of preoperative and postoperative administration of sublingual misoprostol (400 μg) in reducing the amount of blood loss during and 24 hours after CS. Setting: Obstetrics and Gynecology Department, Faculty of Medicine, Assiut University, Assiut, Egypt, between January 2017 and July 2018. Study Design: A prospective, randomized clinical trial. Methods: Four-hundred thirty women fulfilling the inclusions criteria: elective lower segment CS at term (≥37 weeks) with normal fetal heart tracing who accepted to participate in the study. Patients were divided into two groups; Patients assigned to group 1 received 400 μg sublingual misoprostol immediately after urinary catheterization and before skin incision, while patients assigned to group 2 received sublingual misoprostol immediately after skin closure. The primary outcome was the estimation of intraoperative and postoperative blood loss for 24 hours. Results: There was a significant reduction in the intraoperative blood loss in group 1 compared with group 2 (403.51 ± 72.99 vs. 460.99 ± 74.66 ml, respectively). Also, there was a significant reduction in postoperative blood loss in group 1 compared with group 2 with a statistical significance (169.45 ± 12.03 vs. 195.77 ± 13.34 ml, respectively). Postoperative hemoglobin and

References

[1]  Jacobs, D. and Hofmeyr, G. (2004) Extra-Abdominal versus Intra-Abdominal Repair of Uterine Incision at Caesarean Section. Cochrane Database of Systematic Reviews, No. 4, CD000085.
[2]  Mathai, M., Hofmeyr, G.J. and Mathai, N.E. (2013) Abdominal Surgical Incisions for Caesarean Section. Cochrane Database of Systematic Reviews, No. 5, CD004453.
https://doi.org/10.1002/14651858.CD004453.pub3
[3]  American College of Obstetricians and Gynecologists (2006) ACOG Practice Bulletin: Clinical Management Guidelines for Obstetrician-Gynecologists Number 76, October 2006: Postpartum Hemorrhage. Obstetrics & Gynecology, 108, 1039-1047.
https://doi.org/10.1097/00006250-200610000-00046
[4]  Mousa, H.A. and Alfirevic, Z. (2007) Treatment for Primary Postpartum Haemorrhage. Cochrane Database of Systematic Reviews, No. 1, CD003249.
https://doi.org/10.1002/14651858.CD003249.pub2
[5]  Acharya, G., Al-Sammarai, M.T., Patel, N., Al-Habib, A. and Kiserud, T. (2001) A Randomized, Controlled Trial Comparing Effect of Oral Misoprostol and Intravenous Syntocinon on Intra-Operative Blood Loss during Cesarean Section. Acta Obstetricia et Gynecologica Scandinavica, 80, 245-250.
https://doi.org/10.1034/j.1600-0412.2001.080003245.x
[6]  Tang, O.S., Schweer, H., Seyberth, H.W., Lee, W.H. and Ho, P.C. (2002) Pharmacokinetics of Different Routes of Administration of Misoprostol. Human Reproduction, 17, 332-336.
https://doi.org/10.1093/humrep/17.2.332
[7]  Othman, E.R., Fayez, M.F., El Aal, D.E., Mohamed, H.S., Abbas, A.M. and Ali, M.K. (2016) Sublingual Misoprostol versus Intravenous Oxytocin in Reducing Bleeding during and after Cesarean Delivery: A Randomized Clinical Trial. Taiwanese Journal of Obstetrics & Gynecology, 55, 791-795.
https://doi.org/10.1016/j.tjog.2016.02.019
[8]  Shady, N.W., Sallam, H.F., Elsayed, A.H., Abdelkader, A.M., Ali, S.S., Alanwar, A., et al. (2017) The Effect of Prophylactic Oral Tranexamic Acid plus Buccal Misoprostol on Blood Loss after Vaginal Delivery: A Randomized Controlled Trial. The Journal of Maternal-Fetal & Neonatal Medicine, 32, 1806-1812.
https://doi.org/10.1080/14767058.2017.1418316
[9]  Derman, R.J., Kodkany, B.S., Goudar, S.S., Geller, S.E., Naik, V.A., Bellad, M.B., et al. (2006) Oral Misoprostol in Preventing Postpartum Hemorrhage in Resource-Poor Communities: A Randomised Controlled Trial. The Lancet, 368, 1248-1253.
https://doi.org/10.1016/S0140-6736(06)69522-6
[10]  Goldberg, A.B., Greenberg, M.B. and Darney, P.D. (2001) Misoprostol and Pregnancy. The New England Journal of Medicine, 344, 38-47.
https://doi.org/10.1056/NEJM200101043440107
[11]  Hofmeyr, G., Ferreira, S., Nikodem, V.C., Mangesi, L., Singata, M., Jafta, Z., et al. (2004) Misoprostol for Treating Postpartum Haemorrhage: A Randomized Controlled Trial. BMC Pregnancy Childbirth, 4, 16.
https://doi.org/10.1186/1471-2393-4-16
[12]  Mitwaly, A.B., Abbas, A.M. and Abdellah, M.S. (2016) Intra Uterine Extra-Amniotic versus Vaginal Misoprostol for Termination of Second Trimester Miscarriage: A Randomized Controlled Trial. International Journal of Reproductive BioMedicine, 14, 643.
https://doi.org/10.29252/ijrm.14.10.643
[13]  Mitwaly, A.B. and Abbas, A.M. (2017) Intrauterine Extra-Amniotic Misoprostol Solution Is Effective for Termination of Second Trimester Missed Abortion: A Clinical Pilot Descriptive Study. Thai Journal of Obstetrics and Gynaecology, 25, 6-10.
[14]  Maher, M.A., Sayyed, T.M. and Elkhouly, N.I. (2017) Different Routes and Forms of Uterotonics for Treatment of Retained Placenta: A Randomized Clinical Trial. The Journal of Maternal-Fetal & Neonatal Medicine, 30, 2179-2184.
https://doi.org/10.1080/14767058.2016.1242124
[15]  Abbas, A.M. (2019) Different Routes and Forms of Uterotonics for Treatment of Retained Placenta: Methodological Issues. The Journal of Maternal-Fetal & Neonatal Medicine, 32, 1048.
https://doi.org/10.1080/14767058.2017.1377176
[16]  Abdellah, M.S., Abbas, A.M., Hegazy, A.M. and El-Nashar, I.M. (2017) Vaginal Misoprostol Prior to Intrauterine Device Insertion in Women Delivered Only by Elective Cesarean Section: A Randomized Double-Blind Clinical Trial. Contraception, 95, 538-543.
https://doi.org/10.1016/j.contraception.2017.01.003
[17]  Khalaf, M., Amin, A.F., Sayed, Z., El-Nashar, I.M. and Abbas, A.M. (2017) A Randomized Double-Blind Controlled Trial of Two Different Doses of Self-Administered Vaginal Misoprostol for Successful Copper Intrauterine Device Insertion. Middle East Fertility Society Journal, 22, 264-268.
https://doi.org/10.1016/j.mefs.2017.04.002
[18]  Samy, A., Abbas, A.M., Mahmoud, M., Taher, A., Awad, M.H., Hussein, M., et al. (2019) Evaluating Different Pain Lowering Medications during Intrauterine Device Insertion: A Systematic Review and Network Meta-Analysis. Fertility and Sterility, 111, 553-561.e4.
https://doi.org/10.1016/j.fertnstert.2018.11.012
[19]  Marshall, N., Fu, R. and Guise, J. (2011) Impact of Multiple Cesarean Deliveries on Maternal Morbidity: A Systematic Review. American Journal of Obstetrics & Gynecology, 205, 262.e1-262.e8.
https://doi.org/10.1016/j.ajog.2011.06.035
[20]  Mirteimouri, M., Tara, F., Teimouri, B., Sakhavar, N. and Vaezi, A. (2013) Efficacy of Rectal Misoprostol for Prevention of Postpartum Hemorrhage. Iranian Journal of Pharmaceutical Research, 12, 469-474.
[21]  Lapaire, O., Schneider, M.C., Stotz, M., Surbek, D.V., Holzgreve, W. and Hoesli, I.M. (2006) Oral Misoprostol vs. Intravenous Oxytocin in Reducing Blood Loss after Emergency Cesarean Delivery. International Journal of Gynecology & Obstetrics, 95, 2-7.
https://doi.org/10.1016/j.ijgo.2006.05.031
[22]  Ragab, A., Barakat, R. and Alsammani, M.A. (2016) A Randomized Clinical Trial of Preoperative versus Postoperative Misoprostol in Elective Cesarean Delivery. International Journal of Gynecology & Obstetrics, 132, 82-84.
https://doi.org/10.1016/j.ijgo.2015.06.057
[23]  Kumari, K.A., Swathi, E. and Saranu, S. (2016) Impact of Pre-Operative 200 μg (P/R) per Rectal Misoprostol on Blood Loss during and after Cesarean Delivery. International Association of Infant Massage, 3, 49-58.
[24]  Owonikoko, K.M., Arowojolu, A.O. and Okunlola, M.A. (2011) Effect of Sublingual Misoprostol versus Intravenous Oxytocin on Reducing Blood Loss at Cesarean Section in Nigeria: A Randomized Controlled Trial. Journal of Obstetrics and Gynaecology Research, 37, 715-721.
https://doi.org/10.1111/j.1447-0756.2010.01399.x
[25]  Chaudhuri, P., Mandi, S. and Mazumdar, A. (2014) Rectally Administrated Misoprostol as an Alternative to Intravenous Oxytocin Infusion for Preventing Post-Partum Hemorrhage after Cesarean Delivery. Journal of Obstetrics and Gynaecology Research, 40, 2023-2030.
https://doi.org/10.1111/jog.12464

Full-Text

comments powered by Disqus